Pro Medicus Limited (ASX:PME) Insider Anthony Glenning Buys 50 Shares

Pro Medicus Limited (ASX:PME) insider Anthony Glenning purchased 50 shares of the stock in a transaction on Wednesday, March 12th. The stock was bought at an average price of A$219.58 ($138.97) per share, for a total transaction of A$10,979.00 ($6,948.73).

Pro Medicus Price Performance

The stock has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39.

Pro Medicus Increases Dividend

The firm also recently announced a Interim dividend, which will be paid on Thursday, March 20th. Stockholders of record on Thursday, March 20th will be issued a dividend of $0.25 per share. This represents a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. This is a boost from Pro Medicus’s previous Interim dividend of $0.18. Pro Medicus’s dividend payout ratio is presently 56.41%.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.